Brief: Anebulo Pharmaceuticals Approves Plan To Terminate Registration Of Common Stock
23/07/2025 13:07
July 23 (Reuters) - Anebulo Pharmaceuticals Inc ANEB.O: ANEBULO PHARMACEUTICALS APPROVES PLAN TO TERMINATE REGISTRATION OF ITS COMMON STOCK ANEBULO PHARMACEUTICALS INC - APPROVES REVERSE STOCK SPLIT RATIO BETWEEN 1-FOR-2,500 AND 1-FOR-7,500 ANEBULO PHARMACEUTICALS INC - STOCKHOLDERS TO RECEIVE $3.50 PER PRE-SPLIT SHARE Source text: ID:nBw2Kqnx7a Further company coverage: ANEB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anebulo Pharmaceuticals
See all newsAdvisory: Dated alert on Anebulo Pharmaceuticals' voluntary delisting from Nasdaq withdrawn
Anebulo Pharmaceuticals Q2 net loss narrows
Brief: Anebulo Pharmaceuticals Announces Intention To Voluntarily Delist From Nasdaq And Deregister With SEC
Anebulo Pharmaceuticals posts Q1 net loss
Brief: Anebulo Pharmaceuticals Reports Fourth Quarter And Fiscal Year 2025 Financial Results